Sequana Medical NV Company Description

Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, Switzerland, and internationally.

The company products pipeline comprises alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; and Direct Sodium Removal (DSR) for the treatment of fluid overload spread across the body and heart failure.

Sequana Medical NV was founded in 2006 and is headquartered in Gent, Belgium.

Sequana Medical NV

Country	Belgium
Founded	2006
Industry	Medical Devices
Sector	Healthcare
Employees	62
CEO	Ian Crosbie

Contact Details

Address: Kortrijksesteenweg 1112 Gent, 9051 Belgium
Phone	32 9 298 28 28
Website	sequanamedical.com

Stock Details

Ticker Symbol	SEQUA
Exchange	Euronext Brussels
Fiscal Year	January - December
Reporting Currency	EUR
ISIN Number	BE0974340722
SIC Code	3841

Key Executives

Name	Position
Ian Crosbie	Chief Executive Officer and Executive Director
Kirsten Van Bockstaele	Chief Financial Officer
Lies Vanneste	Director of Investor Relations
Gijs Klarenbeek M.D.	MD and Chief Medical Officer
Martijn Blom	Chief Commercial Officer